Prometheus Laboratories

@prometheuslab

A leader of precision healthcare in gastroenterology, offering novel diagnostic testing services to help physicians provide the highest level of patient care

San Diego, CA

prometheuslabs.com

Joined April 2021

128 Following

66 Followers

Replies Reposts Media

Prometheus Laboratories
@prometheuslab
11h
Three clinically relevant insights. One blood draw. MASH Precis combines: ✅Objective fibrosis staging ✅ Prognostic assessment with the ELF® Risk Score ✅Biomarker-level insights MASH Precis is a non-invasive test that aids in identifying treatment-eligible MASH patients to
Prometheus Laboratories
@prometheuslab
23h
Healthcare organizations are increasingly looking for scalable approaches to liver fibrosis assessment that can fit into routine clinical workflows. MASH Precis was designed to fit into emerging MASH assessment pathways with a simple blood draw. One potential pathway: ➡️FIB-4
Prometheus Laboratories
@prometheuslab
Nov 6
New research demonstrates the MASH Precis™ Fibrosis Score improved identification of treatment-eligible F2-F3 MASH patients while reducing uncertainty in fibrosis staging. We're sharing the data at The Liver Meeting today, November 6, in the poster hall. The authors will be at
Prometheus Laboratories
@prometheuslab
Nov 3
Prometheus Laboratories is exhibiting at The Liver Meeting 2026! Visit us at Booth 2268 to learn about our newest non-invasive blood test that aids in identifying treatment-eligible F2-F3 MASH patients. We still have meeting times available – contact your local representative or
Prometheus Laboratories
@prometheuslab
Oct 27
MASLD, formerly known as NAFLD, is the most common chronic liver disease around the world, affecting more than 30% of the global population. Yet millions remain undiagnosed, highlighting the urgent need for earlier detection and diagnosis before the disease silently progresses.

Prometheus Laboratories

Prometheus Laboratories’s posts